231 related articles for article (PubMed ID: 38601153)
21. Roles of the hexosamine biosynthetic pathway and pentose phosphate pathway in bile acid-induced cancer development.
Munemoto M; Mukaisho KI; Miyashita T; Oyama K; Haba Y; Okamoto K; Kinoshita J; Ninomiya I; Fushida S; Taniura N; Sugihara H; Fujimura T
Cancer Sci; 2019 Aug; 110(8):2408-2420. PubMed ID: 31215094
[TBL] [Abstract][Full Text] [Related]
22. Elevated O-GlcNAcylation promotes colonic inflammation and tumorigenesis by modulating NF-κB signaling.
Yang YR; Kim DH; Seo YK; Park D; Jang HJ; Choi SY; Lee YH; Lee GH; Nakajima K; Taniguchi N; Kim JM; Choi EJ; Moon HY; Kim IS; Choi JH; Lee H; Ryu SH; Cocco L; Suh PG
Oncotarget; 2015 May; 6(14):12529-42. PubMed ID: 25915426
[TBL] [Abstract][Full Text] [Related]
23.
Zhang H; Qi J; Pei J; Zhang M; Shang Y; Li Z; Wang Y; Guo J; Sun K; Fan J; Sui L; Xu Y; Kong L; Kong Y
J Adv Res; 2022 Mar; 37():119-131. PubMed ID: 35499042
[TBL] [Abstract][Full Text] [Related]
24. Involvement of NDPK-B in Glucose Metabolism-Mediated Endothelial Damage via Activation of the Hexosamine Biosynthesis Pathway and Suppression of O-GlcNAcase Activity.
Chatterjee A; Eshwaran R; Poschet G; Lomada S; Halawa M; Wilhelm K; Schmidt M; Hammes HP; Wieland T; Feng Y
Cells; 2020 Oct; 9(10):. PubMed ID: 33086728
[TBL] [Abstract][Full Text] [Related]
25.
Zhang Z; Parker MP; Graw S; Novikova LV; Fedosyuk H; Fontes JD; Koestler DC; Peterson KR; Slawson C
J Biol Chem; 2019 Jan; 294(4):1363-1379. PubMed ID: 30523150
[TBL] [Abstract][Full Text] [Related]
26. Role of the O-GlcNAc modification on insulin resistance and endoplasmic reticulum stress in 3T3-L1 cells.
Sermikli BP; Aydogdu G; Yilmaz E
Mol Biol Rep; 2020 Aug; 47(8):5927-5942. PubMed ID: 32691273
[TBL] [Abstract][Full Text] [Related]
27. Protein
Dong H; Liu Z; Wen H
Front Immunol; 2022; 13():805018. PubMed ID: 35185892
[TBL] [Abstract][Full Text] [Related]
28. Ogt-mediated O-GlcNAcylation inhibits astrocytes activation through modulating NF-κB signaling pathway.
Dong X; Shu L; Zhang J; Yang X; Cheng X; Zhao X; Qu W; Zhu Q; Shou Y; Peng G; Sun B; Yi W; Shu Q; Li X
J Neuroinflammation; 2023 Jun; 20(1):146. PubMed ID: 37349834
[TBL] [Abstract][Full Text] [Related]
29. IDH2, a novel target of OGT, facilitates glucose uptake and cellular bioenergy production via NF-κB signaling to promote colorectal cancer progression.
He X; Wu N; Li R; Zhang H; Zhao Y; Nie Y; Wu J
Cell Oncol (Dordr); 2023 Feb; 46(1):145-164. PubMed ID: 36401762
[TBL] [Abstract][Full Text] [Related]
30. Protein O-GlcNAcylation alleviates small intestinal injury induced by ischemia-reperfusion and oxygen-glucose deprivation.
Cong R; Sun L; Yang J; Cui H; Ji X; Zhu J; Gu JH; He B
Biomed Pharmacother; 2021 Jun; 138():111477. PubMed ID: 33765582
[TBL] [Abstract][Full Text] [Related]
31. Epithelial Mesenchymal Transition Induces Aberrant Glycosylation through Hexosamine Biosynthetic Pathway Activation.
Lucena MC; Carvalho-Cruz P; Donadio JL; Oliveira IA; de Queiroz RM; Marinho-Carvalho MM; Sola-Penna M; de Paula IF; Gondim KC; McComb ME; Costello CE; Whelan SA; Todeschini AR; Dias WB
J Biol Chem; 2016 Jun; 291(25):12917-29. PubMed ID: 27129262
[TBL] [Abstract][Full Text] [Related]
32. HBP/O-GlcNAcylation Metabolic Axis Regulates Bone Resorption Outcome.
Taira TM; Ramos-Junior ES; Melo PH; Costa-Silva CC; Alteen MG; Vocadlo DJ; Dias WB; Cunha FQ; Alves-Filho JC; Søe K; Fukada SY
J Dent Res; 2023 Apr; 102(4):440-449. PubMed ID: 36749069
[TBL] [Abstract][Full Text] [Related]
33. O-GlcNAcylation Enhances Double-Strand Break Repair, Promotes Cancer Cell Proliferation, and Prevents Therapy-Induced Senescence in Irradiated Tumors.
Efimova EV; Appelbe OK; Ricco N; Lee SS; Liu Y; Wolfgeher DJ; Collins TN; Flor AC; Ramamurthy A; Warrington S; Bindokas VP; Kron SJ
Mol Cancer Res; 2019 Jun; 17(6):1338-1350. PubMed ID: 30885991
[TBL] [Abstract][Full Text] [Related]
34. Proteomic identification of altered protein O-GlcNAcylation in a triple transgenic mouse model of Alzheimer's disease.
Tramutola A; Sharma N; Barone E; Lanzillotta C; Castellani A; Iavarone F; Vincenzoni F; Castagnola M; Butterfield DA; Gaetani S; Cassano T; Perluigi M; Di Domenico F
Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3309-3321. PubMed ID: 30031227
[TBL] [Abstract][Full Text] [Related]
35. Metabolic sensor O-GlcNAcylation regulates erythroid differentiation and globin production via BCL11A.
Luanpitpong S; Kang X; Janan M; Thumanu K; Li J; Kheolamai P; Issaragrisil S
Stem Cell Res Ther; 2022 Jun; 13(1):274. PubMed ID: 35739577
[TBL] [Abstract][Full Text] [Related]
36. Protein O-GlcNAcylation in multiple immune cells and its therapeutic potential.
Cai H; Xiong W; Zhu H; Wang Q; Liu S; Lu Z
Front Immunol; 2023; 14():1209970. PubMed ID: 37675125
[TBL] [Abstract][Full Text] [Related]
37. Augmented O-GlcNAcylation attenuates intermittent hypoxia-induced cardiac remodeling through the suppression of NFAT and NF-κB activities in mice.
Nakagawa T; Furukawa Y; Hayashi T; Nomura A; Yokoe S; Moriwaki K; Kato R; Ijiri Y; Yamaguchi T; Izumi Y; Yoshiyama M; Asahi M
Hypertens Res; 2019 Dec; 42(12):1858-1871. PubMed ID: 31409917
[TBL] [Abstract][Full Text] [Related]
38. O-GlcNAcylation plays a role in tumor recurrence of hepatocellular carcinoma following liver transplantation.
Zhu Q; Zhou L; Yang Z; Lai M; Xie H; Wu L; Xing C; Zhang F; Zheng S
Med Oncol; 2012 Jun; 29(2):985-93. PubMed ID: 21461968
[TBL] [Abstract][Full Text] [Related]
39. DOT1L O-GlcNAcylation promotes its protein stability and MLL-fusion leukemia cell proliferation.
Song T; Zou Q; Yan Y; Lv S; Li N; Zhao X; Ma X; Liu H; Tang B; Sun L
Cell Rep; 2021 Sep; 36(12):109739. PubMed ID: 34551297
[TBL] [Abstract][Full Text] [Related]
40. Formal modeling and analysis of the hexosamine biosynthetic pathway: role of O-linked N-acetylglucosamine transferase in oncogenesis and cancer progression.
Saeed MT; Ahmad J; Kanwal S; Holowatyj AN; Sheikh IA; Zafar Paracha R; Shafi A; Siddiqa A; Bibi Z; Khan M; Ali A
PeerJ; 2016; 4():e2348. PubMed ID: 27703839
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
